This session focuses on the use of hospital-based HTA in relation to health service delivery models (not medical or pharmaceutical technologies). Speakers from Australia, New Zealand and Singapore will talk about their experiences and views on the (1) prioritisation of topics for hospital-based HTA, (2) methods for hospital-based HTA of delivery models and (3) decision making using completed HTAs.
|Publication status||Published - Jun 2023|
|Event||Health Technology Assessment International (HTAi) 2023 Annual Meeting : The road to policy and clinical integration - Adelaide, Australia|
Duration: 24 Jun 2023 → 28 Jun 2023
|Conference||Health Technology Assessment International (HTAi) 2023 Annual Meeting|
|Abbreviated title||HTAi 2023|
|Period||24/06/23 → 28/06/23|
|Other||The road to policy and clinical integration for health technologies is filled with diverse and complex challenges to overcome, often made more arduous by the intricate and nuanced processes and rules relative to jurisdictions, agencies, policymakers, and systems. Subjugating these challenges requires a harmonized framework to examine and evaluate health technologies, and alignment of processes throughout the health technology lifecycle is crucial.|
Enabling the integration of clinical and policy approaches to health technologies is dependent upon methods for facilitating timely and funded access to clinical innovation for patients and health professionals; horizontal consistency in approaches for evaluating and approving health technologies by regulators and payers; and better vertical alignment in decision-making across all elements in the health system involved with regulation, funding, implementation, and re-assessment. With current legislative developments across Europe and financial pressure throughout the world, most notably felt among developing economies, enabling efficient processes to accelerate access to cost-effective technologies is more pertinent than ever.
Discussions on these topics will explore questions such as:
How can we build pathways to fast-track innovation while minimizing risk?
What supports are required to harmonize HTA processes between similar jurisdictions?
What is the feasibility of aligning technology evaluation processes and decisions in an era of sustainable development?
Bibliographical notePanel session 2 held Tuesday June 27, Session 3, 11:10 - 12:25, PN25
- Health Technology Assessment (HTA)